Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy—Results From a Longitudinal Study
Sanne Menning, Michiel B. de Ruiter, Jacobien M. Kieffer, et al.
Journal of Pain and Symptom Management (2016) Vol. 52, Iss. 4, pp. 560-569.e1
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies
Aicha B. C. Dijkshoorn, Haike E. van Stralen, Maurits Sloots, et al.
Psycho-Oncology (2021) Vol. 30, Iss. 5, pp. 635-648
Open Access | Times Cited: 108
Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis
Alexandra L. Whittaker, Rebecca P. George, Lucy O’Malley
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 105
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
Vincent M. T. de Jong, Yuwei Wang, Natalie D. ter Hoeve, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 21, pp. 2361-2374
Open Access | Times Cited: 90
Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment
Victoria Bray, Haryana M. Dhillon, Janette Vardy
Journal of Cancer Survivorship (2018) Vol. 12, Iss. 4, pp. 537-559
Closed Access | Times Cited: 149
Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study
Sanne Menning, Michiel B. de Ruiter, Dick J. Veltman, et al.
Brain Imaging and Behavior (2017) Vol. 12, Iss. 2, pp. 324-334
Closed Access | Times Cited: 62
Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy
Noemí Cerulla, J. Blas Navarro, Núria de la Osa
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 464-482
Closed Access | Times Cited: 54
Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type
Sanne Menning, Michiel B. de Ruiter, Dick J. Veltman, et al.
PLoS ONE (2017) Vol. 12, Iss. 3, pp. e0171724-e0171724
Open Access | Times Cited: 51
COVID-19 Outbreak Effects on Job Security and Emotional Functioning Amongst Women Living With Breast Cancer
Bethany Chapman, Jessica Swainston, Elizabeth A. Grunfeld, et al.
Frontiers in Psychology (2020) Vol. 11
Open Access | Times Cited: 39
Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis
Eiman Ibrahim, Ilaria Domenicano, Kate Nyhan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 38
Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity
Sona Ciernikova, Michal Mego, Michal Chovanec
Cancers (2021) Vol. 13, Iss. 4, pp. 782-782
Open Access | Times Cited: 34
Effects of Chemotherapy on Attention Function in Breast Cancer Patients: Meta-analysis of Longitudinal Prospective Cohort Studies
Sun Ok Jung, A. Cho, Dong Won Yang, et al.
European Journal of Oncology Nursing (2025) Vol. 75, pp. 102820-102820
Closed Access
Systematic review of longitudinal studies on chemotherapy‐associated subjective cognitive impairment in cancer patients
Hee‐Ju Kim, Sun Ok Jung, Hyang Kim, et al.
Psycho-Oncology (2020) Vol. 29, Iss. 4, pp. 617-631
Closed Access | Times Cited: 38
Relationship of fatigue with cognitive performance in women with early‐stage breast cancer over 2 years
Joseph M. Gullett, Ronald A. Cohen, Gee Su Yang, et al.
Psycho-Oncology (2019) Vol. 28, Iss. 5, pp. 997-1003
Open Access | Times Cited: 33
Influence of a Multidisciplinary Program of Diet, Exercise, and Mindfulness on the Quality of Life of Stage IIA-IIB Breast Cancer Survivors
Julia Ruiz‐Vozmediano, Sarah Löhnchen, Lucas Jurado, et al.
Integrative Cancer Therapies (2020) Vol. 19
Open Access | Times Cited: 28
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 21
Barriers to and Facilitators of Implementing Programs for Return to Work (RTW) of Cancer Survivors in Four European Countries: A Qualitative Study
Sietske J. Tamminga, Anna M. Braspenning, Anna Haste, et al.
Journal of Occupational Rehabilitation (2018) Vol. 29, Iss. 3, pp. 550-559
Open Access | Times Cited: 22
One size does not fit all: An individualized approach to understand heterogeneous cognitive performance in autistic adults
Carolien Torenvliet, Annabeth P. Groenman, Tulsi Radhoe, et al.
Autism Research (2022) Vol. 16, Iss. 4, pp. 734-744
Open Access | Times Cited: 11
Metastatic breast cancer patients’ expectations and priorities for symptom improvement
Danielle B. Tometich, Catherine E. Mosher, Adam T. Hirsh, et al.
Supportive Care in Cancer (2018) Vol. 26, Iss. 11, pp. 3781-3788
Open Access | Times Cited: 19
Usability of an online application for reporting the burden of side effects in cancer patients
Mies van Eenbergen, Corina van den Hurk, Floortje Mols, et al.
Supportive Care in Cancer (2019) Vol. 27, Iss. 9, pp. 3411-3419
Closed Access | Times Cited: 18
Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review
Miaomiao Jia, Xiaojun Zhang, Liyuan Wei, et al.
Asia-Pacific Journal of Clinical Oncology (2020) Vol. 17, Iss. 4, pp. 321-329
Open Access | Times Cited: 16
Role of stress, age and adjuvant therapy in the cognitive function of patients with breast cancer (Review)
A. Papanastasiou, Theodora Seliniotaki, Emmanouil� Rizos, et al.
Oncology Letters (2019)
Open Access | Times Cited: 17
Cancer-Related Neuropathic Pain, Chemotherapy-Induced Peripheral Neuropathy and Cognitive Decline in a 5-Year Prospective Study of Patients with Breast Cancer—NEON-BC
Susana Pereira, Natália Araújo, Filipa Fontes, et al.
Healthcare (2023) Vol. 11, Iss. 24, pp. 3132-3132
Open Access | Times Cited: 5
Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study
Wim Schrauwen, Joris Van de Cavey, Guy Vingerhoets, et al.
Journal of the International Neuropsychological Society (2020) Vol. 26, Iss. 8, pp. 806-814
Open Access | Times Cited: 13
Chemotherapy-related cognitive impairment (CRCI) among early-stage breast cancer survivors in Malaysia
Syarifah Maisarah Syed Alwi, Vairavan Narayanan, Nur Aishah Mohd Taib, et al.
Journal of Clinical and Experimental Neuropsychology (2021) Vol. 43, Iss. 5, pp. 534-545
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top